Neha Krishnamohan - 18 Jul 2024 Form 3 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Chief Financial Officer
Signature
/s/ Jennifer Bush, Attorney-in-Fact
Issuer symbol
ARTV
Transactions as of
18 Jul 2024
Net transactions value
$0
Form type
3
Filing time
18 Jul 2024, 20:01:45 UTC
Previous filing
18 Jun 2024
Next filing
13 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARTV Employee Stock Option (Right to Buy) 18 Jul 2024 Common Stock 102,599 $13.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest on April 15, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.